Bell Biosystems
Berkeley
About Bell Biosystems
Bell Biosystems is a biotechnology company based in Berkeley, CA, and focused on developing tools for the tracking and imaging of cellular therapies. Bell combines expertise in stem cell research, cell biology, biomedical imaging, molecular biology and clinical regenerative medicine. Our vision is to create tools that accelerate the "bench-to-bedside" progress of innovations in cell therapy pre-clinical and clinical delivery and tracking of transplanted cells.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $8.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2015)
- Website: bellbiosystems.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bell-biosystems-2729571 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.